Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: India Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20093
20103
20111
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
AstraZeneca1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Mark Eisenberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome13
Myocardial Infarction4
Angina, Unstable2
Cardiovascular Diseases2
Coronary Artery Disease2
Coronary Disease2
Heart Diseases2
Myocardial Ischemia2
Angina Pectoris1
Arterial Occlusive Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.